Award Ceremony - 4 October 2017
Receiving such a prestigious award is a valued acknowledgement of the hard work that has been required to develop the learning resources over the past three years. Our project has already reached many thousands of health professionals and this award raises the profile of genetic healthcare and will help us to maintain the website and continue to update our materials to help more patients in future.
This award recognises the value the European Antibiotic Awareness Day has in raising prudent antibiotic use and resistance as priorities for governments and health authorities across the European Union and beyond.
The EHA has had an affirming, fertilising, sustaining and developmental effect and impact on our work. We have, in a sense, been empowered, we now have a more international focus, we open up new areas of activity and we use new structures to expand to new regions and countries.
Through EAT more than 1,500 medical students from 28 German, four Austrian and two Swiss medical schools educate 23,800 adolescents effectively in the classroom setting per year, educate hundreds of prospective physicians for tobacco cessation in inpatient settings and conduct the largest school-based tobacco prevention trials worldwide.
EUR-HUMAN aimed to rapidly enhance Primary Health Care capacity across Europe to address refugee and migrant health needs and safeguard them from risks including minimising cross-border care risks. An evidence-based, validated approach was utilised, well-tailored to their needs and matched to available service.
The ECNM is a multi-center network and high-level initiative of EU experts working in the field of mastocytosis. The general aim of the ECNM is to improve recognition, diagnosis and therapy in patients with mastocytosis in Europe and other countries. The ECNM has succeeded in developing widely accepted guidelines for the diagnosis and management of patients with mastocytosis.
Focus IN CD project will demonstrate the development of an innovative health service model and will gain data to develop e-learning tools for health care professionals (HCPs) and patients, to close existing knowledge gaps and to improve patient support.
EU SHIPSAN ACT focused on the impact of maritime transport on health threats due to biological, chemical and radiological agents including communicable diseases. The project aimed to strengthen an integrated strategy and sustainable mechanisms at the EU level for safeguarding the health of travellers and crew of passenger and cargo ships, and preventing the cross-border spread of diseases to improve citizens' health security.
Initiatives & projects must comply with the following criteria to be eligible for consideration:
If you are interested in finding out more about the European Health Award, have questions about the selection process, please contact:
Josef Wenninger, MSc
T: +43 662 4224 0012
M: +43 664 2444 998